ESCITALOPRAM RESPONSE IS ASSOCIATED WITH CHANGES IN ENDOCANNABINOID SIGNALING IN ADOLESCENTS WITH GENERALIZED ANXIETY DISORDER: A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

被引：0
|
作者：
Strawn, Jeffrey [1 ]
Mills, Jeffrey [1 ]
Schroeder, Heidi [1 ]
Marusak, Hilary [1 ]
机构：
[1] Univ Cincinnati, Coll Med, Cincinnati, OH USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2024年 / 49卷
关键词：
Anxiety; SSRI; escitalopram; Endocannabinoids;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P437
引用
收藏
页码：311 / 312
页数：2
相关论文
共 50 条
  • [1] A MULTICENTER DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ESCITALOPRAM IN CHILDREN AND ADOLESCENTS WITH GENERALIZED ANXIETY DISORDER
    Strawn, Jeffrey Robert
    Moldauer, Leslie
    Hahn, Rebekah D.
    Wise, Alexandria
    Bertzos, Kristina
    Eisenberg, Beth
    Greenberg, Edward F.
    Liu, Chengcheng
    Gopalkrishnan, Mallika
    Mcvoy, Molly
    Knutson, James A.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2022, 61 (10): : S185 - S185
  • [2] A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder
    Strawn, Jeffrey R.
    Moldauer, Leslie
    Hahn, Rebekah D.
    Wise, Alexandria
    Bertzos, Kristina
    Eisenberg, Beth
    Greenberg, Edward
    Liu, Chengcheng
    Gopalkrishnan, Mallika
    McVoy, Molly
    Knutson, James A.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2023, 33 (03) : 91 - 100
  • [3] Escitalopram in Adolescents With Generalized Anxiety Disorder: A Double-Blind, Randomized, Placebo-Controlled Study
    Strawn, Jeffrey R.
    Mills, Jeffrey A.
    Schroeder, Heidi
    Mossman, Sarah A.
    Varney, Sara T.
    Ramsey, Laura B.
    Poweleit, Ethan A.
    Desta, Zeruesenay
    Cecil, Kim
    DelBello, Melissa P.
    JOURNAL OF CLINICAL PSYCHIATRY, 2020, 81 (05)
  • [4] Response to Ploderl et al. re: "A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder"
    Strawn, Jeffrey R.
    Mills, Jeffrey A.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2024, 34 (02) : 106 - 107
  • [5] Escitalopram in Adolescents With Generalized Anxiety Disorder: A Double-Blind, Randomized, Placebo-Controlled Study With Pharmacogenomic and Pharmacokinetic Measures
    Strawn, Jeffrey
    Mills, Jeffrey
    Schroeder, Heidi
    Mossman, Sarah
    Varney, Sara
    Ramsey, Laura
    Poweleit, Ethan
    Desta, Zeruesenay
    Cecil, Kim
    DelBello, Melissa
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 88 - 89
  • [6] A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder (vol 33, pg 91, 2023)
    Strawn
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2023, 33 (05) : 200 - 200
  • [7] Response to Plöderl et al. re: "A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder"
    Strawn, Jeffrey R.
    Mills, Jeffrey A.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2024,
  • [8] BASELINE EXECUTIVE FUNCTION AND ITS RELATIONSHIP TO ESCITALOPRAM RESPONSE IN ADOLESCENTS WITH ANXIETY: A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Baumel, William Thomas
    Mills, Jeffrey A.
    Schroeder, Heidi K.
    Specht, Ashley M.
    Rothenberg, Richard
    Peris, Tara S.
    Strawn, Jeffrey Robert
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2022, 61 (10): : S185 - S185
  • [9] Escitalopram in the treatment of multisomatoform disorder: a double-blind, placebo-controlled trial
    Muller, Jacqueline E.
    Wentzel, Ignatius
    Koen, Liezl
    Niehaus, Dana J. H.
    Seedat, Soraya
    Stein, Dan J.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (01) : 43 - 48
  • [10] Efficacy and tolerability of agomelatine in generalized anxiety disorder (gad) : A randomised double-blind, placebo-controlled trial with escitalopram as validator
    Stein, D.
    Marquez, M. S.
    Hoeschl, C.
    Ahokas, A.
    Oh, K. S.
    Jarema, M.
    Avedisova, A.
    Vavrusova, L.
    Olivier, V.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 94 - 95
12345